BenzingaSeptember 16, 2026 at 5:09 AM NYLast Month
BMO Capital Maintains Outperform on Corteva, Lowers Price Target to $95
BMO Capital analyst Joel Jackson maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $100 to $95.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
